Celsius Holdings, Inc. (CELH) Stock Forecast
Data as of Jul 31, 2026Consumer Defensive · Current price $29.02 (-1.21%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 17, 2026 | Eric Serotta | Morgan Stanley | $64.00 | +120.6% |
| Nov 26, 2025 | Peter Grom | UBS | $65.00 | +124.0% |
| Oct 24, 2025 | Matthew Smith | Stifel Nicolaus | $74.00 | +155.0% |
| Sep 30, 2025 | Eric Serotta | Morgan Stanley | $70.00 | +141.3% |
| Sep 8, 2025 | Bill Chappell | Truist Financial | $70.00 | +141.3% |
| Sep 8, 2025 | Michael Lavery | Piper Sandler | $69.00 | +137.8% |
| Sep 3, 2025 | Kaumil Gajrawala | Jefferies | $72.00 | +148.1% |
| Aug 29, 2025 | Kaumil Gajrawala | Jefferies | $64.00 | +120.6% |
| Aug 11, 2025 | Bill Chappell | Truist Financial | $65.00 | +124.0% |
| Aug 8, 2025 | Gerald Pascarelli | Needham | $60.00 | +106.8% |
| Sep 27, 2024 | Sean McGowan | Roth Capital | $43.00 | +48.2% |
| Sep 24, 2024 | Michael Lavery | Piper Sandler | $47.00 | +62.0% |
| Sep 19, 2024 | Kevin Grundy | BNP Paribas | $58.00 | +99.9% |
| Sep 5, 2024 | Bill Chappell | Truist Financial | $30.00 | +3.4% |
| Sep 5, 2024 | Anthony Vendetti | Maxim Group | $50.00 | +72.3% |
| Sep 5, 2024 | Sean McGowan | Roth Capital | $45.00 | +55.1% |
| Sep 5, 2024 | Michael Lavery | Piper Sandler | $50.00 | +72.3% |
| Sep 5, 2024 | Mark Astrachan | Stifel Nicolaus | $51.00 | +75.8% |
| Aug 20, 2024 | Eric Serotta | Morgan Stanley | $50.00 | +72.3% |
| Aug 8, 2024 | Jonathan Keypour | Bank of America Securities | $32.00 | +10.3% |
Top Analysts Covering CELH
CELH vs Sector & Market
| Metric | CELH | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.57 | 2.42 |
| Analyst Count | 15 | 10 | 19 |
| Target Upside | +83.7% | +1206.2% | +18.0% |
| P/E Ratio | 131.89 | 10.93 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.22B | $3.38B | $3.51B | 17 |
| 2027-03-31 | $792M | $840M | $884M | 6 |
| 2027-06-30 | $942M | $999M | $1.05B | 6 |
| 2027-09-30 | $906M | $961M | $1.01B | 6 |
| 2027-12-31 | $837M | $888M | $934M | 6 |
| 2028-03-31 | $898M | $953M | $1.00B | 5 |
| 2028-06-30 | $1.01B | $1.07B | $1.12B | 5 |
| 2028-09-30 | $934M | $991M | $1.04B | 6 |
| 2028-12-31 | $879M | $933M | $981M | 8 |
| 2029-12-31 | $4.00B | $4.25B | $4.51B | 5 |
| 2030-12-31 | $4.30B | $4.56B | $4.84B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.22 | $1.60 | $1.90 | 14 |
| 2027-03-31 | $0.38 | $0.41 | $0.44 | 5 |
| 2027-06-30 | $0.53 | $0.58 | $0.62 | 5 |
| 2027-09-30 | $0.54 | $0.58 | $0.62 | 5 |
| 2027-12-31 | $0.40 | $0.43 | $0.46 | 5 |
| 2028-03-31 | $0.49 | $0.53 | $0.56 | 6 |
| 2028-06-30 | $0.61 | $0.66 | $0.70 | 6 |
| 2028-09-30 | $0.56 | $0.60 | $0.64 | 7 |
| 2028-12-31 | $0.42 | $0.45 | $0.48 | 9 |
| 2029-12-31 | $2.22 | $2.41 | $2.60 | 4 |
| 2030-12-31 | $2.47 | $2.67 | $2.89 | 2 |
Frequently Asked Questions
What is the analyst consensus for CELH?
The consensus among 15 analysts covering Celsius Holdings, Inc. (CELH) is Buy with an average price target of $50.25.
What is the highest price target for CELH?
The highest price target for CELH is $115.00, set by Mark Astrachan at Stifel Nicolaus on 2022-08-21.
What is the lowest price target for CELH?
The lowest price target for CELH is $24.44, set by Sean McGowan at Roth Capital on 2023-09-21.
How many analysts cover CELH?
15 analysts have issued ratings for Celsius Holdings, Inc. in the past 12 months.
Is CELH a buy or sell right now?
Based on 15 analyst ratings, CELH has a consensus rating of Buy (2.00/5) with a +83.7% upside to the consensus target of $50.25.
What are the earnings estimates for CELH?
Analysts estimate CELH will report EPS of $1.60 for the period ending 2026-12-31, with revenue estimated at $3.38B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.